{"id":11347,"date":"2024-02-23T20:50:58","date_gmt":"2024-02-23T20:50:58","guid":{"rendered":"https:\/\/www.johnsonfistel.com\/?post_type=investigations&p=11347"},"modified":"2024-02-26T13:35:53","modified_gmt":"2024-02-26T13:35:53","slug":"akero-therapeutics-inc","status":"publish","type":"investigations","link":"https:\/\/www.johnsonfistel.com\/investigations\/akero-therapeutics-inc","title":{"rendered":"Akero Therapeutics, Inc."},"content":{"rendered":"\n

Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Behalf of <\/strong>Akero Therapeutics<\/strong> Shareholders<\/strong><\/h2>\n\n\n\n

Shareholder rights law firm Johnson Fistel, LLP is investigating whether Akero Therapeutics, Inc. (“Akero” or “the Company”) (NASDAQ: AKRO) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors\u2019 losses and whether they may be recovered under federal securities laws.<\/p>\n\n\n\n

What if I purchased <\/strong>Akero <\/strong>securities? <\/strong>If you purchased securities and suffered significant losses on your investment, join our investigation now:<\/p>\n\n\n